How Henry Ford Health Integrated Clinical Trials into Clinical Care

Summary:

The Henry Ford Health system has prioritized clinical trials across their entire system, and accomplished it through a three-step strategy. In this podcast from the 2023 CRAACO: Clinical Research as a Care Option conference, Jennifer Levy, David Lanfear, Henry Ford Health, describe how they worked with Donna O'Brien, Manatt Health, to assess their system's capacity for clinical trials and the conscientious steps they took to ensure that clinical research was viable, scalable and quantifiable. 

Specifically, they discuss: 

• The three-step system

• Implementing operational challenges by bringing four sites into one and doubling the number of patients in a diverse population who would now have access to clinical research

• Establishing a five-year strategic plan to triple the amount of patients, embed research and education into clinical care

To learn more about CRAACO: Clinical Research as a Care Option, visit CRAACOevent.com.

Jennifer Gibson Levy

VP, Education

Henry Ford Health System

Jennifer Gibson Levy

VP, Education
Henry Ford Health System

Jennifer Shaw Gibson Levy is Vice President, Education and System Academic Enterprise for Henry Ford Health. In this role, she provides system-wide strategic, operational, and financial management support for the academic mission of Henry Ford Health and works to identify and implement operational strategies and initiatives to address system, hospital, and medical education and research programmatic goals to ensure program quality and consistency.

David Lanfear, MD, MS

VP Clinical and Translational Research

Henry Ford Health System

David Lanfear, MD, MS

VP Clinical and Translational Research
Henry Ford Health System

David E. Lanfear, MD, MS, Professor of Medicine, is System Vice President for Clinical and Translational Research, and Co-Director of the Center for Individualized and Genomic Medicine Research (CIGMA). Dr. Lanfear is a practicing transplant cardiologist, a clinician scientist focused on precision medicine and genomics, and an active clinical trialist with experience in single and multicenter trials. 

Donna O'Brien, MHA

National Advisor

Manatt Health

Donna O'Brien, MHA

National Advisor
Manatt Health

Donna M. O’Brien, MHA, is a National Advisor with Manatt Health providing strategy development and program implementation advice to healthcare providers and research institutes. Prior to this, Donna served as Consultant to the Director of the NCI for nine years to support the development and implementation of a new program model for cancer care delivery and research expansion in 30 hospitals in 22 states. She was a member of the team that designed the NCI Community Oncology Research Program (NCORP). She was also an executive at MD Anderson Cancer Center in Houston and Executive Vice President of the Catholic Health Long Island.